{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:27Z","timestamp":1761100707780},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,5,5]],"date-time":"2004-05-05T00:00:00Z","timestamp":1083715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We performed allogeneic bone marrow transplantation (BMT) with an extended period of post\u2010transplant intrathecal (IT) chemotherapy for five patients with acute lymphoblastic leukaemia and non\u2010Hodgkin's lymphoma who had relapsed in the central nervous system either in the very early phase or more than twice. Post\u2010transplant IT was scheduled for a total of 12 doses over 18\u2003months. One patient was found to have subclinical leucoencephalopathy. Disease relapse occurred in one patient and the other patients remained in complete remission for 39\u2013196\u2003months post\u2010BMT. The estimated event\u2010free survival was 80\u2003\u00b1\u200317\u00b79% (standard error).<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.04975.x","type":"journal-article","created":{"date-parts":[[2004,6,3]],"date-time":"2004-06-03T12:11:36Z","timestamp":1086264696000},"page":"766-768","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of isolated central nervous system relapse in high\u2010risk lymphoid malignancy with allogeneic bone marrow transplantation and extended intrathecal therapy"],"prefix":"10.1111","volume":"125","author":[{"given":"Yoshihisa","family":"Nagatoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,5,5]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311902"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108093450606"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04158.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2004.00161.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430511"},{"key":"e_1_2_9_8_1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V92.2.411","article-title":"Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia","volume":"92","author":"Pui C.\u2010H.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.333"},{"key":"e_1_2_9_10_1","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1200\/JCO.1999.17.12.3745","article-title":"Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a Pediatric Oncology Group Study","volume":"17","author":"Ritchy A.K.","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_9_11_1","first-page":"3310","article-title":"Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial radiotherapy: results of trial ALL\u2010BFM 90","volume":"95","author":"Schrappe M.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V67.1.195.195"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00676.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.04975.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.04975.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.04975.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:25:18Z","timestamp":1697423118000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.04975.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,5]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1365-2141.2004.04975.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.04975.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,5]]},"assertion":[{"value":"2004-05-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}